EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Risks Associated With Benzodiazepine Long‐Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta‐Analysis

Dieter Riemann iD, Chiara Baglioni iD, Christoph Nissen iD, Agathe Nevière iD, Omar Irfan iD, Pauline Le Nouveau iD, Chrysoula Leontiou iD, Damien Léger iD

Journal of Sleep Research · 2026-10 · 35 (5)

DOI: 10.1111/jsr.70352 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Sleep Research, online erschienen am 11.06.2026. Verfasst von Dieter Riemann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Benzodiazepines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Idorsia Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic literature review evaluated the risks of using benzodiazepine medications for more than 3 months in adults with chronic insomnia. Chronic insomnia is defined as ongoing dissatisfaction with sleep quantity or quality, causing significant distress and impaired functioning during the day. Although benzodiazepine medications are often prescribed to treat insomnia, using them longer than 4 weeks raises concerns about dependence, negative side effects, and long‐term health risks for patients. This review included 27 studies published between 1987 and 2023, focusing on adults with insomnia symptoms lasting at least 3 months. The main outcomes examined were sleep quality, safety issues such as risk of falls, mental health concerns including depression and anxiety, and overall quality of life. Five outcomes were deemed suitable for meta‐analysis: severity of insomnia, sleep quality, incidence of falls, depression, and anxiety. The results showed that people taking benzodiazepine medications had more severe insomnia than healthy sleepers, but less severe than those who were not taking any medication. The risk of falls was similar between those using benzodiazepine medications and those who were not. However, people using these medications experienced significantly higher levels of depression and anxiety compared to healthy sleepers. This review highlights a lack of studies on the long‐term use of benzodiazepine medications, but suggests that extended use may worsen sleep quality, mental health, and quality of life. The findings support guidelines recommending limited use and prioritizing behavioural therapy and alternative safer pharmacotherapies for insomnia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Initiation and Maintenance DisordersBenzodiazepinesHumansQuality of LifeAccidental FallsDepressionSleep QualityAnxietyChronic Disease

Stichwörter der Autor:innen

benzodiazepineschronic insomniainsomniameta‐analysissystematic review

Substanzen

Benzodiazepines

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, Medical Center, University of Freiburg, Faculty of Medicine University of Freiburg, Freiburg, Germany.
  • Department of Human Sciences, University of Rome 'G. Marconi'-Telematic, Rome, Italy.
  • Department of Psychiatry, University Hospital Geneva, Geneva, Switzerland.
  • Health Economics and Market Access, Amaris Consulting, Saint-Herblain, France.
  • Health Economics and Market Access, Amaris Consulting, Toronto, Ontario, Canada.
  • Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.

ORCID-Profile: Dieter Riemann, Chiara Baglioni, Christoph Nissen, Agathe Nevière, Omar Irfan, Pauline Le Nouveau, Chrysoula Leontiou, Damien Léger

Förderung

  • Idorsia Pharmaceuticals

Zitieren

APA

Riemann, D., Baglioni, C., Nissen, C., Nevière, A., Irfan, O., Le Nouveau, P., Leontiou, C., & Léger, D. (2026). Risks Associated With Benzodiazepine Long‐Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta‐Analysis. Journal of Sleep Research, 35(5). https://doi.org/10.1111/jsr.70352

Vancouver

Riemann D, Baglioni C, Nissen C, Nevière A, Irfan O, Le Nouveau P, et al. Risks Associated With Benzodiazepine Long‐Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta‐Analysis. Journal of Sleep Research. 2026;35(5). doi:10.1111/jsr.70352

BibTeX
@article{Riemann2026,
  author = {Riemann, Dieter and Baglioni, Chiara and Nissen, Christoph and Nevière, Agathe and Irfan, Omar and Le Nouveau, Pauline and Leontiou, Chrysoula and Léger, Damien},
  title = {Risks Associated With Benzodiazepine Long‐Term Use in Chronic Insomnia: A Systematic Review and (Network) Meta‐Analysis},
  journal = {Journal of Sleep Research},
  year = {2026},
  volume = {35},
  number = {5},
  doi = {10.1111/jsr.70352}
}
Kostenlos starten →